Introduction
Mycobacterium fortuitum is a recognised cause of soft tissue infections at different sites in humans, for example, the cervical region, 1 abdominal wall, 2 skin 3 and breast. 4 In the literature, only a few cases of M. fortuitum prosthetic infections have been reported. The outcome was poor with inevitable failure of reimplantation except in one case. 5 There is no consensus of treatment.
Case report
A 64-year-old woman had osteoarthritis of both knees. Preoperative X-rays of her left knee ( Figure 1 ) showed no obvious sign of infection. There had been a history of intra-articular injection of unknown drugs of both knees before left total knee arthroplasty ( Figure 2 ) (Legacy posterior stabilized knee, Warsaw, Zimmer) was performed in 2003. Preoperative and intraoperative assessments showed no signs of infection. At 10 weeks after the operation, the patient complained of increased pain in her left knee. Physical examination showed increased temperature in the left knee with effusion. The blood test showed an elevated C-reactive protein level of 48.9 mg/L. Left knee aspiration was done and joint fluid was sent for investigation. Joint fluid culture was negative but microscopy found an increased number of neutrophils. Acid-fast bacillus smear was negative. Acid-fast bacillus culture yielded M. fortuitum, which was sensitive to amikacin, ciprofloxacin and imipenem but resistant to rifampicin, tetracycline and clarithromycin.
Exploration was done 12 weeks after the first operation. Intraoperatively, pus was found inside the joint. Removal of the implant and insertion of a hand-moulded articulating cement spacer made from one pack of antibiotic-loaded cement (500 mg tobramycin in 40 g Simplex cement) were performed (Figure 3 ). Intraoperative frozen section showed >20 neutrophils per high-power field (40Â). Intraoperative fluid culture showed mycobacterial species. After the operation, the patient was placed on intravenous amikacin (500 mg/day) for 6 weeks and oral ciprofloxacin (500 mg twice daily orally) for 6 weeks in total, as suggested by the microbiologist. Two months after insertion of the cement spacer, the pain improved and signs of inflammation subsided. The extension to flexion range of her left knee was 10e80 . The C-reactive protein level went down from 48.9 mg/L to 5.0 mg/L. One month later, revision total knee replacement (Figure 4 ) was done. Intraoperative frozen section confirmed that the neutrophils count was <5 per high-power field. Antibiotic-loaded cement (1 g tobramycin in 40 g Simplex cement) was used. After the operation, 2 weeks of oral ciprofloxacin (500 mg twice daily) was given empirically. Tissue culture was negative.
At the latest follow-up about 7 years after the reimplantation operation, there was no recurrence of infection. The extension to flexion range of her left knee was 0e70 . The patient could walk painlessly with a stick.
Discussion
M. fortuitum belongs to Runyon group IV, called rapidly growing mycobacterium in the classification of nontuberculous mycobacteria. Extracellular hemolysis is a possible pathogenesis process of the disease owing to haemolysin production by M. fortuitum. 6 This group of mycobacteria has proven in vitro susceptibility to amikacin, gatifloxacin, moxifloxacin, ciprofloxacin, and norfloxacin, with amikacin being the drug of first choice followed by the newer generation of fluoroquinolones.
7
Prosthetic infection by M. fortuitum has rarely been reported. The outcome was not satisfactory with failure of reimplantation. It could also happen after hip arthroplasty. 9 To the best of our knowledge, this is the second case reported in the literature of an infected total knee arthroplasty with subsequent successful reimplantation. Prolonged duration of combination antibiotics for at least 6 months has been recommended. 5, 8 In our case, however, successful reimplantation was achieved with 6 weeks treatment with systemic antibiotics with antibioticloaded cementation in contrast to the suggestion in previous reports. Our case demonstrated that a shorter duration (6 weeks amikacin and ciprofloxacin) would be effective in vivo in treating prosthetic infection caused by M. fortuitum if there was supplementation with antibiotic-loaded cementation locally during the reimplantation. This could reduce the treatment cost and minimise adverse effects of prolonged systemic antibiotics.
In conclusion, the exact duration of antibiotics and timing of reimplantation surgery remain uncertain for the treatment of M. fortuitum infection of total joint arthroplasty. Also, the role and exact regime of antibiotics used in cement spacer is not well defined. However, radical debridement, tobramycin-loaded articulated cement spacers, and 6 weeks of systemic combination antibiotics, followed by reimplantation after infection is cleared, may lead to successful reimplantation.
